Both minerals sit within the antioxidant defence system that shields sperm from oxidative stress, and both are concentrated in the male reproductive tract
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
2009 Mar Khingkan Lertratanangkoon, Chun J Wu, Niramol Savaraj, Mary L Thomas
Demelash A, Pfannenstiel LW, Liu L, Gastman BR
Zhang X, Liu F, Bao H, Wang A, Han M, Wu X, et al